Jinhai Medical Technology Limited (Jinhai Med Tech) announced a series of board changes effective 18 September 2026. Key developments include the appointment of Ms. Liu Jinjing as an independent non-executive director (INED) and the resignations of Mr. Li Yunping (executive director) and Ms. Yang Meihua (INED).
Ms. Liu Jinjing, 39, brings over 15 years of finance and audit experience to the board. Her background spans roles as Finance Director at Passion Group since June 2021, Chief Financial Officer at Shanghai Nanyan Information Technology Co., Ltd. (2018–2021), and Audit Manager at BDO China Shu Lun Pan CPAs LLP (2013–2018). A PRC-licensed certified public accountant, Ms. Liu holds a bachelor’s degree in finance from Zhejiang University Ningbo Institute of Technology. She has signed a one-year appointment letter with an annual director’s fee of HK$0.12 million. Ms. Liu has confirmed her independence in accordance with Listing Rule 3.13 and reports no shareholding in the company.
Concurrently, Mr. Li Yunping and Ms. Yang Meihua have stepped down due to other business commitments. Their departures trigger multiple committee adjustments: • Audit Committee – Ms. Liu replaces Ms. Yang. • Nomination Committee – Ms. Liu joins, while Mr. Li and Ms. Yang exit. • Remuneration Committee – Ms. Liu replaces Ms. Yang.
Following these changes, Jinhai Med Tech’s board remains at seven members: three executive directors (Mr. Chen Guobao, Mr. Li Bin, Mr. Wang Zhenfei), one non-executive director (Mr. Wang Huasheng), and three independent non-executive directors (Mr. Yan Jianjun, Mr. Fan Yimin, Ms. Liu Jinjing).
The board expressed gratitude to the outgoing directors for their service and welcomed Ms. Liu to her new role.
Comments